Showing results (31-40 of 1,297) with videos related to
Sort By:
Pageof 130
Future Oncology (London, England)|August 8, 2008
Optimizing denileukin diftitox (Ontak) therapyMadeleine Duvic, Rakhshandra TalpurExpert Opinion on Investigational Drugs|June 28, 2007
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphomaMadeleine Duvic, Jenny VuDrugs of Today (Barcelona, Spain : 1998)|October 18, 2007
Vorinostat in cutaneous T-cell lymphomaMadeleine Duvic, Jenny VuClinical Lymphoma, Myeloma & Leukemia|April 24, 2012
Pilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous peripheral T-cell lymphomasRakhshandra Talpur, Madeleine DuvicClinical Lymphoma & Myeloma|June 27, 2006
Treatment of mycosis fungoides with denileukin diftitox and oral bexaroteneRakhshandra Talpur, Madeleine DuvicInternational Journal of Dermatology|May 22, 2016
Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantationRamya Chockalingam, Madeleine DuvicAmerican Journal of Clinical Dermatology|November 16, 2018
Antibody-Based Therapies for Cutaneous T-Cell LymphomaMacartney Welborn, Madeleine DuvicBiologics : Targets & Therapy|August 27, 2009
Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostatMadeleine Duvic, Jenny VuSkinmed|October 23, 2014
Antinuclear antibody seropositivity in men with cutaneous B-cell lymphoma of the scalpSophia Rangwala, Madeleine DuvicInternational Journal of Dermatology|July 14, 2012
Prevalence and severity of pruritus in cutaneous T cell lymphomaAlok Vij, Madeleine DuvicPageof 130